1
Home
Companies

Petros Pharmaceuticals

Petros Pharmaceuticals
Leadership team

Mr. Mitchell S. Arnold M.B.A. (VP of Fin. & Chief Accounting Officer)

Mr. John D. Shulman (Exec. Chairman)

Mr. Fady Boctor M.B.A. (Principal Exec. Officer, Pres & Chief Commercial Officer)

Products/ Services
Health Care, Men's, Pharmaceutical
Headquarters
New York, New York, United States
Established
2016
Company Registration
SEC CIK number: 0001815903
Revenue
2M - 5M
Social Media
URL
https://www.petrospharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
History

Founded in 2000 by Stanly and Mary Peterson, Petros Pharmaceuticals started as a small, local pharmacy in Pacific Coast. Now, Petros Pharmaceuticals has grown to be a leading provider of medicinal products globally.

Mission
Our mission is to provide the highest quality of pharmaceuticals and to exceed customer expectations with exceptional customer service and product innovation.
Vision
Our vision is to become the gold standard provider of medicinal products in the world.
Key Team

Mr. Robert Weinstein (Interim Chief Financial Officer)

Mr. Keith F. Lavan (Advisor)

Recognition and Awards
We are proud to have won the North American Pharmaceutical award for most innovative product for three consecutive years in a row.
References

https://in.investing.com/equities/petros-pharmaceuticals

https://finance.yahoo.com/quote/PTPI/profile?p=PTPI

https://www.crunchbase.com/organization/petros-pharmaceuticals

https://companiesmarketcap.com/

https://www.petrospharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Petros Pharmaceuticals
Leadership team

Mr. Mitchell S. Arnold M.B.A. (VP of Fin. & Chief Accounting Officer)

Mr. John D. Shulman (Exec. Chairman)

Mr. Fady Boctor M.B.A. (Principal Exec. Officer, Pres & Chief Commercial Officer)

Products/ Services
Health Care, Men's, Pharmaceutical
Headquarters
New York, New York, United States
Established
2016
Company Registration
SEC CIK number: 0001815903
Revenue
2M - 5M
Social Media
URL
https://www.petrospharma.com